Episode 304: A PSMA CD3 Bispecific T-cell Engager in CRPC

Release Date:

Tanya Dorff describes acapatamab, a prostate-specific membrane antigen (PSMA) CD3 bispecific engager.

Episode 304: A PSMA CD3 Bispecific T-cell Engager in CRPC

Title
Episode 304: A PSMA CD3 Bispecific T-cell Engager in CRPC
Copyright
Release Date

flashback